Navigation Links
Reportlinker Adds Proteomics - Technologies, Markets and Companies
Date:9/7/2010

proteomics for pharmacodynamics153

CellCarta® proteomics platform153

ZeptoMARK protein profiling system154

Role of proteomics in targeting disease pathways154

Identification of protein kinases as drug targets154

Mechanisms of action of kinase inhibitors155

G-protein coupled receptors as drug targets155

Methods of study of GPCRs156

Cell-based assays for GPCR156

Companies involved in GPCR-based drug discovery157

GPCR localization database158

Matrix metalloproteases as drug targets158

PDZ proteins as drug targets159

Proteasome as drug target159

Serine hydrolases as drug targets160

Targeting mTOR signaling pathway160

Targeting caspase-8 for anticancer therapeutics161

Bioinformatic analysis of proteomics data for drug discovery162

Drug design based on structural proteomics162

Protein crystallography for determining 3D structure of proteins162

Automated 3D protein modeling163

Drug targeting of flexible dynamic proteins163

Companies involved in structure-based drug-design163

Integration of genomics and proteomics for drug discovery164

Ligand-receptor binding165

Role of proteomics in study of ligand-receptor binding165

Aptamer protein binding166

Systematic Evolution of Ligands by Exponential Enrichment166

Aptamers and high-throughput screening166

Nucleic Acid Biotools167

Aptamer beacons167

Peptide aptamers168

Riboreporters for drug discovery168

Target identification and validation168

Application of mass spectrometry for target identification169

Gene knockout and gene suppression for validating protein targets169

Laser-mediated protein knockout for target validation169

Integrated proteomics for drug discovery170

High-throughput proteomics170

Companies involved in high-throughput proteomics171

Dr
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related biology technology :

1. Reportlinker Adds Biotechnology Pharmaceutical Market in US -2013
2. Reportlinker Adds US Vaccines Market
3. Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies
4. Reportlinker Adds Womens Infertility - Pipeline Assessment and Market Forecasts to 2017
5. Reportlinker Adds Womens Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis Markets
6. Reportlinker Adds Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies
7. Reportlinker Adds Commercializing Peptides in Oncology: A Decision Support Tool for Optimizing the Pipeline
8. Reportlinker Adds Protein Kinase Therapeutics in Oncology - Where to Commercialize?
9. Reportlinker Adds Target Atlas: Competitive Insights to Anti-Angiogenic Drug R&D in Oncology
10. Reportlinker Adds Advances in Biopharmaceutical Technology in China
11. Reportlinker Adds Bioinformatics Market - Advanced Technologies, Global Forecast and Winning Imperatives (2009 - 2014)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... Wendel – recipient of a Regional Top Doctor Award for ... Surgeon Specialists for Nashville, TN – has released a new ... Hydration Booster, Retexturing Night Crème, and Anti-aging C Complex, all ... radiant appearance while protecting them from the sun’s harmful UV ... Dr. J. J. Wendel Plastic Surgery, we have developed a ...
(Date:7/29/2014)... 29, 2014 ... zur Erfassung biologischer Daten in Verbindung mit ... patentiert. Das LBS nimmt gleichzeitig mehrere Blutproben ... Patienten und sucht erhöhte biologische Aktivitäten in ... die Entdeckung und Entwicklung neuer Medikamente und ...
(Date:7/28/2014)... Reston, VA (PRWEB) July 28, 2014 ... leading nonprofit authority on the use of health IT ... its Health Plan Identifier (HPID) Workgroup has ... Between a Health Plan and Payer?” The HPID Workgroup, ... worked closely with the Centers for Medicare and Medicaid ...
(Date:7/28/2014)... 28, 2014 Proove Biosciences , ... be exhibiting data and research conducted through their latest ... Intervention Society’s (ISIS) 22nd Annual Scientific Meeting. The ... Hyatt Regency, in Orlando, Florida. , The ... competence of physicians who care for patients suffering specificity ...
Breaking Biology Technology:Dr. J. J. Wendel Launches New Line of Skin Care Products 2PlaqueTec sichert sich CE-Kennzeichnung für Liquid Biopsy System - bahnbrechende Innovation zur Erfassung neuer biologischer Informationen aus erkranktem Herzkranzgefäß 2PlaqueTec sichert sich CE-Kennzeichnung für Liquid Biopsy System - bahnbrechende Innovation zur Erfassung neuer biologischer Informationen aus erkranktem Herzkranzgefäß 3PlaqueTec sichert sich CE-Kennzeichnung für Liquid Biopsy System - bahnbrechende Innovation zur Erfassung neuer biologischer Informationen aus erkranktem Herzkranzgefäß 4WEDI’s HPID Workgroup Announces Release of Issue Brief: “What is the Difference Between a Health Plan and Payer?” 2Proove Biosciences Exhibits Industry Leading Data and Research at International Spine Intervention Society’s 22nd Annual Scientific Meeting 2
... Shows No Thrombosis, Low MACE Rates ... Thirty Patients, ABBOTT PARK, Ill., March 13 ... first clinical trial of a,fully bioabsorbable drug eluting stent ... thrombosis, no clinically driven target,lesion revascularizations (retreatment of a ...
... BERKELEY, Calif., March 13 Nile Therapeutics,Inc. (OTC ... and,full year financial results for 2007. Participants may ... the investor relations section of,Nile,s website at ... company,s website until the next quarterly conference call., ...
... Unigene,Laboratories, Inc. (OTCBB: UGNE) announced that it ... release titled "Stonegate Report About Unigene,Laboratories Inc.", ... Company,s,policies and procedures, Unigene does not endorse, ... by analysts and unrelated third,parties. Any opinions, ...
Cached Biology Technology:The Lancet Publishes Results From World's First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent 2The Lancet Publishes Results From World's First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent 3The Lancet Publishes Results From World's First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent 4Nile Therapeutics Reports 2007 Fourth Quarter and Full Year Financial Results 2Nile Therapeutics Reports 2007 Fourth Quarter and Full Year Financial Results 3Unigene Restates Policy on Analyst Reports 2
(Date:7/29/2014)... affects 1 in 100,000 people characterized by a loss ... remains unknown, a new study by a team of researchers ... Germany and other European institutions confirms for the first time ... 6 July in Nature Genetics , is an important ... a sphincter in the lower esophagus opens, allowing food to ...
(Date:7/28/2014)... by the U.S. Food and Drug Administration (FDA) for ... bacterial pathogens inside human cells, including those that cause ... published in mBio , the online open-access journal ... way of identifying non-antibiotic drugs that could one day ... drugs on the list inhibit the growth of at ...
(Date:7/28/2014)... by the University of Arizona has sequenced the complete ... enhance scientists, and agriculturalists, understanding of the growing patterns ... of new rice varieties that are better able to ... hunger challenges. , The paper, "The genome sequence of ... independent domestication," was published online in Nature Genetics ...
Breaking Biology News(10 mins):Mysterious esophagus disease is autoimmune after all 2New route to identify drugs that can fight bacterial infections 2Generating a genome to feed the world: UA-led team sequences African rice 2Generating a genome to feed the world: UA-led team sequences African rice 3Generating a genome to feed the world: UA-led team sequences African rice 4
... Hospital have discovered a new genetic disease that can lead ... bile is missing, the liver cells are exposed to the ... a transformation of liver cells into connective tissue with a ... the cases of liver cirrhosis of unknown origin and open ...
... Meyskens, Jr., M.D., one of the "fathers" of ... to receive the seventh annual American Association for ... in Cancer Prevention Research. The award is ... to the field of cancer prevention research in ...
... Jewish Health have identified a simple gene-based blood test ... response to therapy than current tests. The test, a ... and help clear a backlog of promising medications now ... the results of a small "proof-of-principal" trial in the ...
Cached Biology News:Toxic bile damages the liver 2Meyskens honored with AACR-Prevent Cancer Foundation award 2New test promises quicker, more accurate evaluation for cystic fibrosis patients 2New test promises quicker, more accurate evaluation for cystic fibrosis patients 3
A robust formulation of Taq Polymerase supplied with a 10X colored reaction buffer which allows Direct Gel-Loading...
...
Borrelia Burgdorfen (IgG) -Ab EIA Sample Size: 100 l...
... inhibitor that noncovalently binds and inactivates neutral pancreatic ... RNase 1, T1, T2, H, U1, U2 or ... inhibitor in that it has a more robust ... RNase in the absence of DTT or other ...
Biology Products: